Attitudes of clinicians following large-scale pharmacogenomics implementation. - Wikidata - wikimedia - TriplyDB

Attitudes of clinicians following large-scale pharmacogenomics implementation.

Attitudes of clinicians following large-scale pharmacogenomics implementation.

http://www.wikidata.org/entity/Q36573086

about

Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.Physician response to implementation of genotype-tailored antiplatelet therapy.Healthcare provider education to support integration of pharmacogenomics in practice: the eMERGE Network experience.On the readiness of physicians for pharmacogenomics testing: an empirical assessment.Integrating Pharmacogenomics into Clinical Practice: Promise vs Reality.Direct-to-consumer genetic testing: Perspectives on its value in healthcare.Pharmacogenetics in Cardiovascular Medicine.Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers.Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.The challenges of implementing pharmacogenomic testing in the clinic.Benefit of pre-emptive pharmacogenetic information on clinical outcome.Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait User considerations in assessing pharmacogenomic tests and their clinical support tools

P2860

Q33717221-1A486EC0-7A0F-45CB-8BDD-791AA8076A35 Q36171560-95E4A4CB-80DE-4244-9F4A-CCA5A6B4E1E6 Q36984543-D5A553F7-FBD5-4509-8E85-4408F05C08D4 Q38668130-49B39642-694D-4141-887A-14BDE5910720 Q38728697-1B2A690C-3355-480D-9437-D54D7031C83C Q38870275-3E01E137-6EC7-4D12-9593-DD313F54BF22 Q40133270-6D37065A-B3C0-4078-AF40-F6FF2DB7D2C7 Q47130405-FB27930E-0350-4159-BE4E-4443C0B57BA1 Q47277604-769D664E-958E-4C46-86B2-A6D3D6D608D2 Q47551037-B6CA5B45-8F85-45F1-81CA-36BC761B6DAE Q47929031-538C0742-4522-411C-93E3-F2CFD9ED0AE2 Q49612005-F2216312-8D9F-454D-9CC6-E866DB678148 Q50108150-6CFC7245-CAE5-449D-B4B9-2E61BE273989 Q57160932-6A836F29-CE35-46E4-BD54-A8354B6915FA Q57646588-9D87C17D-5278-4149-8374-852D05558F1D

P2860

Attitudes of clinicians following large-scale pharmacogenomics implementation.

http://www.wikidata.org/entity/Q36573086

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Attitudes of clinicians following large-scale pharmacogenomics implementation.

@ast

Attitudes of clinicians following large-scale pharmacogenomics implementation.

@en

type

label

Attitudes of clinicians following large-scale pharmacogenomics implementation.

@ast

Attitudes of clinicians following large-scale pharmacogenomics implementation.

@en

prefLabel

Attitudes of clinicians following large-scale pharmacogenomics implementation.

@ast

Attitudes of clinicians following large-scale pharmacogenomics implementation.

@en

P1433

Q36573086-55E11FC2-C793-4983-A303-C7F6CCE6D4DF

P1476

Q36573086-87E756ED-F1DD-4BC8-B9F1-070E52941D0F

P2093

Q36573086-18DA44AE-DAD9-49F3-951F-1AB0E20BF747

Q36573086-381C8040-5E9E-4769-9DAA-C9803D6F7AAA

Q36573086-3C4FBDC8-089D-4BDF-964F-1FF08DD6799E

Q36573086-5F6BB8B5-990F-4660-861E-D2B7C43B8C64

Q36573086-711C2050-BACB-4B6D-B6AC-B00657687139

Q36573086-79C3D86D-A50D-4C3D-BEAC-EB3AC2A6D905

Q36573086-CBBD15C0-9EE7-4F40-9068-55C34450F03A

Q36573086-D71F32A5-0217-4291-9B82-5578DBC859FC

Q36573086-DBB2CD1B-4765-4A94-BE78-F18317EED6AD

Q36573086-FAC6F088-8472-4DD3-8AF8-DFDE2B9FC7CE

P2860

Q36573086-03F350F0-008E-4FFC-A759-D474B3AC2D7C

Q36573086-0F812E07-2121-42C4-AA5C-07AAE2C1A633

Q36573086-27323A3A-F3BE-4076-BC08-7E5FF3DD0DD5

Q36573086-2A800242-84AE-4D9D-B43B-E95C487F8340

Q36573086-33B7FD46-806B-4937-BCDF-1F2D74249EE9

Q36573086-347EE9EF-E87A-46CC-8A33-196002D0B8DC

Q36573086-388E632A-C0A4-48A9-B306-37F145ED07E5

Q36573086-39F877DF-EF0B-476C-ABB6-E3D0041222BE

Q36573086-5C5BA183-4ACE-403C-AFFD-F6E066F468EE

Q36573086-6E12D156-F61C-4C27-8C1D-8D835D1B16C3

P2888

Q36573086-8D89E789-F7B7-4DFD-8432-EF81AED8A692

P304

Q36573086-0B27E5C2-A72D-4DCC-873E-C41D1FB13DBE

P31

Q36573086-5BA0C580-15B3-48A3-9D03-52B75EE3AF75

P356

Q36573086-760FBA05-F63C-48FB-954D-28DAF3746D48

P433

Q36573086-0A2F974D-4154-44C7-A3E3-8A97B74FA045

P478

Q36573086-83E676C5-C78E-4908-B9F6-64A04364633E

P50

Q36573086-09D860AF-F997-4EBD-9D51-12BED397E60B

P577

Q36573086-5F1C952D-AA1D-4209-8B5A-4E9C89D676D1

P698

Q36573086-F4EF2727-D9EB-4FEF-AFB4-FB5FB6257129

P921

Q36573086-6B40FD7D-F629-4B8E-9030-80E45E7C0956

P932

Q36573086-4B65CF24-F74D-49A1-BF63-4FC6A342E39F

P356

P1433

The Pharmacogenomics Journal

P1476

Attitudes of clinicians following large-scale pharmacogenomics implementation.

@en

P2093

D M Roden

http://www.w3.org/2001/XMLSchema#string

E W Clayton

http://www.w3.org/2001/XMLSchema#string

I M Lubin

http://www.w3.org/2001/XMLSchema#string

J F Peterson

http://www.w3.org/2001/XMLSchema#string

J M Pulley

http://www.w3.org/2001/XMLSchema#string

J R Field

http://www.w3.org/2001/XMLSchema#string

J S Schildcrout

http://www.w3.org/2001/XMLSchema#string

M Laposata

http://www.w3.org/2001/XMLSchema#string

S L Van Driest

http://www.w3.org/2001/XMLSchema#string

T L McGregor

http://www.w3.org/2001/XMLSchema#string

P2860

Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol

PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.

Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling.

A surveillance tool to support quality assurance and research in personalized medicine

Professional perspectives about pharmacogenetic testing and managing ancillary findings

Primary care physicians' knowledge of and experience with pharmacogenetic testing

P2888

P304

393-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/TPJ.2015.57

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26261062

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

4751074

http://www.w3.org/2001/XMLSchema#string